You et al. observed enhanced anti-tumor activity of TIGIT+ γδ T cells compared to their TIGIT− counterparts, which is also in contrast to the paradigm of immune checkpoint function and patient derived data [63,64]. Here, TIGIT is linked to neoplasm.